€9.21
1.26% day before yesterday
Frankfurt, Dec 23, 08:01 am CET
ISIN
SE0017769995
Symbol
BGLA

BioGaia Stock price

€9.21
+0.10 1.04% 1M
+0.29 3.25% 6M
+0.02 0.22% YTD
+0.16 1.80% 1Y
+2.52 37.59% 3Y
+0.23 2.57% 5Y
+3.97 75.64% 10Y
+8.91 2,941.61% 20Y
Frankfurt, Closing price Tue, Dec 23 2025
+0.12 1.26%
ISIN
SE0017769995
Symbol
BGLA
Industry

Key metrics

Basic
Market capitalization
€968.3m
Enterprise Value
€901.0m
Net debt
positive
Cash
€67.4m
Shares outstanding
101.2m
Valuation (TTM | estimate)
P/E
31.8 | 31.5
P/S
7.2 | 7.0
EV/Sales
6.7 | 6.5
EV/FCF
30.2
P/B
8.6
Dividends
DPS
€0.63
Yield 1Y | 5Y
1.9% | 1.4%
Growth 1Y | 5Y
15.7% | 23.5%
Payout 1Y | 3Y
197.5% | 144.3%
Increased
4 Years
Financials (TTM | estimate)
Revenue
€135.3m | €138.9m
EBITDA
€34.2m | €39.6m
EBIT
€36.5m | €36.6m
Net Income
€29.2m | €29.6m
Free Cash Flow
€29.8m
Growth (TTM | estimate)
Revenue
7.9% | 5.5%
EBITDA
-22.5% | 2.9%
EBIT
-1.4% | -3.3%
Net Income
-6.2% | -9.0%
Free Cash Flow
-11.8%
Margin (TTM | estimate)
Gross
72.7%
EBITDA
25.3% | 28.5%
EBIT
27.0%
Net
21.6% | 21.3%
Free Cash Flow
22.0%
Financial Health
Equity Ratio
84.8%
Return on Equity
20.4%
ROCE
30.1%
ROIC
-
Debt/Equity
0.0
More
EPS
€0.3
FCF per Share
€0.3
Short interest
-
Employees
225
Rev per Employee
€590.0k
Show more

Is BioGaia a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

BioGaia Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a BioGaia forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a BioGaia forecast:

Buy
80%
Hold
20%

Financial data from BioGaia

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
135 135
8% 8%
100%
- Direct Costs 37 37
11% 11%
27%
98 98
7% 7%
73%
- Selling and Administrative Expenses 49 49
22% 22%
37%
- Research and Development Expense 10 10
26% 26%
8%
34 34
23% 23%
25%
- Depreciation and Amortization -2.35 -2.35
133% 133%
-2%
EBIT (Operating Income) EBIT 37 37
1% 1%
27%
Net Profit 29 29
6% 6%
22%

In millions EUR.

Don't miss a Thing! We will send you all news about BioGaia directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Michael Rothschild in 1990 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Theresa Agnew
Employees 225
Founded 1990
Website sv.biogaia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today